Michael Roost Clausen (Michael R Clausen)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Venues

American journal of hematology

European journal of haematology

Clinical epidemiology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Vejle Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vejle Hospital Sep 01 2018

Denmark

Senior Consultant :: Department of Hematology

Department of Haematology, Aarhus University Hospital Dec 01 2007 - Aug 31 2018

Denmark

M.D. :: Department of Haematology

Publications

Jelena Jelicic, Karen Juul-Jensen, Zoran Bukumiric, Mikkel Runason Simonsen, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Robert Schou Pedersen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter Brown, Tarec Christoffer El-Galaly, Thomas Stauffer Larsen
A Real-World Data-Based Analysis of Prognostic Indices as Part of Trial Eligibility Criteria in Diffuse Large B-Cell Lymphoma Patients. European journal of haematology (2024)
Rasmus Rask Kragh Jørgensen, Lasse Hjort Jakobsen, Sandra Eloranta, Karin E Smedby, Robert Schou Pedersen, Judit M Jørgensen, Michael Roost Clausen, Peter Brown, Anne Ortved Gang, Inger-Lise Gade, Thomas Stauffer Larsen, Mats Jerkeman, Tarec Christoffer El-Galaly
Effectiveness of R-CHOP versus R-CHOEP for treatment of young patients with high-risk diffuse large B-cell lymphoma: A Danish observational population-based study. European journal of haematology (2024)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Eva Futtrup Maksten, Lasse Hjort Jakobsen, Kristian Hay Kragholm, Joachim Baech, Mikkel Porsborg Andersen, Jakob Madsen, Judit Mészáros Jørgensen, Michael Roost Clausen, Robert Schou Pedersen, Andriette Dessau-Arp, Thomas Stauffer Larsen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter Brown, Kirsten Fonager, Tarec C El-Galaly, Marianne Tang Severinsen
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study. Clinical epidemiology 15 (2023)
Eva Futtrup Maksten, Lasse Hjort Jakobsen, Kristian Hay Kragholm, Joachim Baech, Mikkel Porsborg Andersen, Jakob Madsen, Judit Mészáros Jørgensen, Michael Roost Clausen, Robert Schou Pedersen, Andriette Dessau-Arp, Thomas Stauffer Larsen, Christian Bjørn Poulsen, Anne Ortved Gang, Peter Brown, Kirsten Fonager, Tarec C El-Galaly, Marianne Tang Severinsen
Work Disability and Return to Work After Lymphoma: A Danish Nationwide Cohort Study. Clinical epidemiology 15 (2023)
Ahmed Ludvigsen Al-Mashhadi, Henrik Cederleuf, Rasmus Kuhr Jensen, Torsten Holm Nielsen, Martin Bjerregård Pedersen, Thomas Bech Mortensen, Thomas Relander, Mats Jerkeman, Anne Ortved Gang, Anne Louise Kristensen, Michael Roost Clausen, Peter de Nully Brown, Marianne Tang Severinsen, Lasse Hjort Jakobsen, Fredrik Ellin, Tarec Christoffer El-Galaly
Outcome of limited-stage peripheral T-Cell lymphoma after CHOP(-like) therapy: A population based study of 239 patients from the Nordic lymphoma epidemiology group. American journal of hematology 98 (3) (2023)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Maja Bech Juul, Jelena Jelicic, Pavithra Laxsen Anru, Henriette Engberg, Pernille Hammershøj Jensen, Helene Bjørg Kristensen, Joachim Bæch, Michael Roost Clausen, Anne Ortved Gang, Lars Munksgaard, Tarec Christoffer El-Galaly, Henrik Frederiksen, Thomas Stauffer Larsen
Cardiovascular diseases in elderly survivors of diffuse large B-cell lymphoma: a Danish population-based cohort study. Leukemia & lymphoma 63 (9) (2022)
Catherine Thieblemont, Tycel Jovelle Phillips, Hervé Ghesquières, Chan Yoon Y Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Mariana Cota Stirner, Nurgul Kilavuz, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliott, Tahamtan Ahmadi, Martin Hutchings, Pieternella J Lugtenburg
Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell-Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Joachim Bæch, Marianne Tang Severinsen, Andreas K Øvlisen, Henrik Frederiksen, Peter Vestergaard, Christian Torp-Pedersen, Judit Meszaros Jørgensen, Michael Roost Clausen, Christian B Poulsen, Peter de Nully Brown, Anne Ortved Gang, Robert Schou Pedersen, Karin Ekström Smedby, Sandra Eloranta, Lasse Hjort Jakobsen, Tarec Christoffer El-Galaly
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapy. Blood advances 6 (15) (2022)
Andreas Glenthøj, Lasse H Jakobsen, Henrik Sengeløv, Syed A Ahmad, Kristian Qvist, Annika Rewes, Christian B Poulsen, Ulrik M Overgaard, Ingolf Mølle, Marianne T Severinsen, Casper N Strandholdt, Jack Maibom, Annette R Kodahl, Jesper Ryg, Pernille Ravn, Isik S Johansen, Søren N Helsø, Søren Jensen-Fangel, Jacek Kisielewicz, Lothar Wiese, Marie Helleberg, Ole Kirk, Michael Roost Clausen, Henrik Frederiksen
SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study. European journal of haematology 106 (1) (2020)
Michael Roost Clausen, Sinna P Ulrichsen, Maja B Juul, Christian B Poulsen, Brian Iversen, Per T Pedersen, Jakob Madsen, Robert S Pedersen, Pär L Josefsson, Jette S Gørløv, Mette Nørgaard, Francesco d'Amore
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study. Hematological oncology 38 (3) (2020)
Michael Roost Clausen, Matthew John Maurer, Sinna Pilgaard Ulrichsen, Thomas S Larsen, Bodil Himmelstrup, Dorthe Rønnov-Jessen, Brian K Link, Andrew L Feldman, Susan L Slager, Grzegorz S Nowakowski, Carrie A Thompson, Per Trøllund Pedersen, Jakob Madsen, Robert S Pedersen, Jette Sønderskov Gørløv, James R Cerhan, Mette Nørgaard, Francesco D'Amore
Pretreatment Hemoglobin Adds Prognostic Information To The NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma Treated With Anthracycline-Containing Chemotherapy. Clinical epidemiology 11 (2019)

Michael Roost Clausen.css-eqlu8i{font-size:small;padding-left:4px;} (Michael R Clausen)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael Roost Clausen (Michael R Clausen)